Previous Article | Next Article ![]()
Journal of Virology, November 1998, p. 9069-9078, Vol. 72, No. 11
Marion Merrell Dow Laboratory of Viral
Pathogenesis and Department of Microbiology, Molecular Genetics,
and Immunology, University of Kansas Medical Center, Kansas City,
Kansas 661601;
NCI-Frederick Cancer
Research, Frederick, Maryland 217022; and
Yerkes Regional Primate Research Center, Emory
University, Atlanta, Georgia 303223
Received 5 June 1998/Accepted 24 July 1998
The chimeric simian-human immunodeficiency virus
SHIVKU-1, bearing the envelope of human immunodeficiency
virus type 1 (HIV-1), causes fulminant infection with subtotal loss of
CD4+ T cells followed by development of AIDS in
intravaginally inoculated macaques and thus provides a highly relevant
model of sexually transmitted disease caused by HIV-1 in human beings.
Previous studies using this SHIV model had shown that the
vpu and nef genes were important in
pathogenesis of the infection, and so we deleted portions of these
genes to create two vaccines,
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Oral Immunization of Macaques with Attenuated
Vaccine Virus Induces Protection against Vaginally Transmitted
AIDS
vpu
nefSHIV-4 (vaccine 1) and
vpuSHIVPPc (vaccine 2). Six adult macaques
were immunized subcutaneously with vaccine 1, and six were immunized orally with vaccine 2. Both viruses caused infection in all inoculated animals, but whereas vaccine 1 virus caused only a nonproductive type
of infection, vaccine 2 virus replicated productively but transiently
for a 6- to 10-week period. Both groups were challenged 6 to 7 months
later with pathogenic SHIVKU-1 by the intravaginal route.
All four unvaccinated controls developed low CD4+ T-cell
counts (<200/µl) and AIDS. The 12 vaccinated animals all became
infected with SHIVKU-1, and two in group 1 developed a persistent productive infection followed by development of AIDS in one.
The other 10 have maintained almost complete control over virus
replication even though spliced viral RNA was detected in lymph nodes.
This suppression of virus replication correlated with robust antiviral
cell-mediated immune responses. This is the first demonstration of
protection against virulent SHIV administered by the intravaginal
route. This study supports the concept that sexually transmitted HIV
disease can be prevented by parenteral or oral immunization.
*
Corresponding author. Mailing address: Marion Merrell
Dow Laboratory of Viral Pathogenesis, University of Kansas Medical
Center, 3901 Rainbow Blvd., Kansas City, KS 66160-7424. Phone: (913)
588-5575. Fax: (913) 588-5599. E-mail: bnarayan{at}kumc.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»